Search results

Collaborative research predicted the distortion and performance of metal parts made by laser deposition.

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.

With world-class experts in groundwater and major contributions in this area over two decades, ANSTO completed a major project report on Improving groundwater sustainability and renewability using isotope hydrochemistry in NSW for the Department of Planning and Environment (NSW) and National Water Grid earlier in the year.

ANSTO is collaborating on a project funded with an Australian Research Council linkage grant that will develop new materials and better systems for efficiently storing hydrogen gas.

The University of Newcastle and UNSW [GW1] are using advanced neutron scattering techniques at ANSTO to carry out research on the structure of polymers in complex salt environments that will ultimately provide a way to predict their behaviour for real-world applications.

Australia’s nuclear agency ANSTO is continuing to lead planning efforts to repatriate what is called a TN-81 cask of intermediate-level radioactive from the United Kingdom in 2022.

ANSTO is taking its innovative ANSTO Synroc® and CORIS360® technologies to the world stage at the Waste Management Symposia 2024 in Phoenix, Arizona USA this week (10 – 14 March 2024). Joining over 45 other countries and around 3,000 attendees, an Australian Government contingent comprising of ANSTO and the Australian Radioactive Waste Agency is in attendance to showcase Australia’s extensive radioactive waste management capabilities.

The ARC Centre of Excellence (CoE) for Green Electrochemical Transformation of Carbon Dioxide, GETCO2, will support innovative approaches to carbon capture.

ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.  

The Macromolecular Crystallography beamlines at the Australian Synchrotron (MX1 and MX2) are general purpose crystallography instruments for determining chemical and biological structures.

An ANSTO radiochemist has been awarded a scholarship to carry out research at the world-renowned Sloan Kettering Cancer Center in New York.

The 3D structure of a fungal and plant enzyme solves 50-year-old mystery.

Two approaches use existing low cost and low energy technologies to reuse stockpiled waste from mining operations - capturing carbon dioxide in the form of valuable carbonate minerals.

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia